SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-017765
Filing Date
2018-06-22
Accepted
2018-06-22 18:20:34
Documents
1
Period of Report
2018-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4109
  Complete submission text file 0000899243-18-017765.txt   5626
Mailing Address BAIN CAPITAL, LLC 200 CLARENDON STREET BOSTON MA 02116
Business Address
PATRICK DEVAL L (Reporting) CIK: 0001053466 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 18915571
SIC: 4512 Air Transportation, Scheduled

Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations